M

    MYNZ (MYNZ)

    Official site

    DIAGNOSTICS & RESEARCH

    $1.42
    -0.05 (-3.40%)

    Last updated: Aug 28, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(8/14)
    Avg Surprise
    -936.38%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    		$0.00N/A+100.00%Beat+100.0%
    Jun 25
    		$-2.65$-2.40-10.42%Miss-
    Mar 25
    		$-7.71$-2.80-175.36%Miss-3112.5%
    Dec 24
    		$-7.71$-6.40-20.47%Miss-3112.5%
    Sep 24
    		$-19.60$-0.15-12966.67%Miss-4925.6%
    Jun 24
    		$N/A$-9.00N/ABeat-
    Mar 24
    		$-0.24$-0.32+25.00%Beat+46.7%
    Dec 23
    		$-0.24$-0.32+24.22%Beat+47.8%
    Sep 23
    		$-0.39$-0.47+17.02%Beat+9.3%
    Jun 23
    		$-0.56$-0.42-33.33%Miss-21.7%
    Mar 23
    		$-0.45$-0.46+2.17%Beat+46.4%
    Dec 22
    		$-0.46$-0.46+0.00%Beat-1433.3%
    Sep 22
    		$-0.43$-0.43+0.00%Beat-2050.0%
    Jun 22
    		$-0.46$-0.46+0.00%Beat-284.0%
    Mar 22
    		$-0.84$-0.49-71.43%Miss-
    Dec 21
    		$-0.03$0.00N/AMiss-
    Sep 21
    		$-0.02$0.00N/AMiss-
    Mar 21
    		$-0.12$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.04EV/EBITDAN/A
    Price/FCF-0.16xFCF Yield-644.54%
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROIC-617.13%
    Financial Health
    Debt/Equity0.64xInterest Coverage-37.59x
    Current Ratio0.52xQuick Ratio0.43x
    Trading Statistics
    BetaN/AAvg Volume796.79K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.39
    SMA 20$1.40
    SMA 50$1.35
    SMA 200$1.19
    EMA 10$1.39
    EMA 20$1.37
    EMA 50$1.40
    EMA 200$1.48

    MACD

    Line: 0.01Signal: 0.00Hist: 0.01

    ADX

    ADX: 20.1+DI: 28.1-DI: 16.8

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down12.0
    PSAR$1.56

    Bollinger Bands

    Upper Band$1.53
    Lower Band$1.26
    %B Position1910%(Upper)
    Band Width0.59

    RSI (14-Day)

    Neutral
    53.1

    Momentum Oscillators

    Stoch %K49.4
    Stoch %D41.3
    Williams %R-51.0
    ROC (10d)-3.7%
    Momentum-0.06
    CCI (20d)39.6
    MFI (14d)60.5

    Volatility Measures

    ATR (14d)$0.13(9.5%)
    StdDev (20d)0.07
    Hist Vol100.2%(High)

    Volume Flow

    VWAP$1.43
    OBV927.1M
    AD Line134.3M
    CMF (20d)0.034

    Volume Metrics

    Avg Vol (20d)833.1K
    Vol Ratio0.7x
    VWMA (20d)$1.41

    Pivot Points

    R3$1.65
    R2$1.58
    R1$1.52
    Pivot Point$1.45
    S1$1.39
    S2$1.32
    S3$1.26

    Advanced Oscillators

    TSI3.11
    Ultimate Osc46.8
    KST105.66

    Financial Data

    QuarterJun 2025Dec 2024Sep 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Total Revenue$286,717$373,218$520,773$214,761$214,761$181,669$500,208$251,397$144,337$96,791$278,480$160,037
    Cost of Revenue$597,058$117,373$201,735$163,494$80,027$94,483$222,326$217,988N/A$78,178$129,738$334,954
    Gross Profit$-310,341$255,845$319,038$40,251$134,734$87,186$277,882$33,409N/A$18,613$148,742$-174,917
    Operating Expenses$7.78M$9.14M$10.13M$13.90M$7.01M$5.73M$13.25M$12.45M$8.48M$5.49M$13.91M$11.08M
    R&D$2.77M$2.60M$3.24M$3.85M$2.00M$1.85M$5.25M$2.96M$0$909,003$696,288$260,543
    SG&A$2.88M$3.56M$4.52M$3.53M$4.78M$2.75M$4.82M$7.37M$2.35M$3.98M$10.46M$8.23M
    Operating Income$-8,091,348$-8,888,080$-9,807,328$-12,231,036$-6,800,018$-5,640,638$-12,975,112$-12,278,938N/A$-5,475,593$-13,895,816$-9,469,972
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$215,260$1.08M$659,473$662,861$0$659,119$146,720$289,324$0$120,634$60,382$84,792
    Income Before Tax$-8,344,211$-10,626,901$-11,023,762$-5,183,327$-5,183,327$-6,299,757$-13,121,832$-12,509,914$0$-5,596,227$-13,877,422$-11,428,377
    Income Tax Expense$0$0$0$1.97M$0$0$146,720$-213,143$0$0$278,532$84,792
    Net Income$-8,344,211$-10,626,901$-11,023,762$-5,183,327$-5,183,327$-6,299,757$-13,268,552$-12,575,303N/A$-5,596,227$-13,877,422$-11,428,377
    EBITDA$-7,743,485$-10,087,211$-9,471,180$-12,610,796N/A$-5,437,064$-12,400,408$-11,877,419$-2,830,353$-5,402,686$-13,840,796$-9,498,234
    EBIT$-8,091,348$-10,768,100$-9,807,328$-13,070,613$-6,800,018$-5,640,638$-12,975,112$-12,281,823N/A$-5,475,593$-13,895,818$-9,469,972
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MYNZ

    News

    Mainz Biomed N V Ord Shs (QUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates

    The article provides an earnings forecast for Mainz Biomed N V Ord Shs (QUCY), detailing its current stock price, market capitalization, and a lack of analyst ratings or specific financial forecast data like EPS, Revenue, Net Profit, and EBIT. It also includes a peer comparison for other healthcare providers and services companies. The content emphasizes that relevant financial data has not yet been disclosed by the company.

    TradingKey•8/7/26•
    Neutral

    Mainz Biomed N V Ord Shs (QUCY) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article from TradingKey provides an earnings forecast for Mainz Biomed N V Ord Shs (QUCY), including anticipated EPS and Revenue growth estimates. It briefly touches on the company's market cap, current stock price, and links to further analysis sections like Financials, Discussions, and TradingKey Stock Score. The content also lists peer comparisons with analyst ratings.

    TradingKey•7/30/26•
    Neutral

    Mainz Biomed N V Ord Shs (QUCY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

    This article provides a revenue breakdown for Mainz Biomed N V Ord Shs (QUCY), stating that relevant data for business segments and regional revenue and profit contribution have not yet been disclosed by the company. It lists the stock's current trading price, market cap, and links to other financial analysis sections on the TradingKey platform.

    TradingKey•7/27/26•
    Neutral

    QUCY|Mainz Biomed N V Ord Shs|Price:1.095|Chg%:+0.015

    This article provides detailed real-time market data and analysis for Mainz Biomed N V Ord Shs (QUCY) as of July 27, 2026. It includes key financial figures, technical indicators, top shareholders, and related instruments. The stock closed at $1.105, up 2.31%, with a market capitalization of $2.56 million.

    TradingKey•7/27/26•
    Neutral

    Mainz Biomed N V Ord Shs (QUCY) Balance Sheet

    This article presents the balance sheet for Mainz Biomed N V Ord Shs (QUCY), detailing its assets, liabilities, and shareholders' equity for FY2026Q1. It provides financial figures for current and non-current items, including cash, receivables, total assets, and total liabilities. The article also includes a Q&A section explaining key balance sheet metrics and their significance for investors.

    TradingKey•7/27/26•
    Neutral

    Frequently Asked Questions About MYNZ

    Does MYNZ pay dividends?
    MYNZ (MYNZ) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In